Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-19

Clinical Trial Update: Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression [NA]

View source ↗

Summary

A completed clinical trial evaluating carbamazepine for irritability and aggression after chronic traumatic brain injury; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Traumatic Brain Injury | NA | Status: COMPLETED | Results posted: 2021-08-19